Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 9/2014

01-09-2014 | Nephrology - Letter to the editor

End-stage renal disease in tuberous sclerosis complex-polycystic kidney disease contiguous gene syndrome: epidemiology, clinical manifestations and implications for transplantation

Authors: Cynthia C. Lim, Huizhuan Tan, Sobhana Thangaraju, Angeline H. M. Lai, Marjorie W. Y. Foo

Published in: International Urology and Nephrology | Issue 9/2014

Login to get access

Excerpt

Editor, …
Literature
1.
Roach E, Gomez M, Northrup H (1998) Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13(12):624–628PubMedCrossRef
2.
Rakowski SK, Winterkorn EB, Paul E, Steele DJR, Halpern EF, Thiele EA (2006) Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 70(10):1777–1782PubMedCrossRef
3.
Schillinger F, Montagnac R (1996) Chronic renal failure and its treatment in tuberous sclerosis. Nephrol Dial Transplant 11(3):481–485PubMedCrossRef
4.
Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease—a contiguous gene syndrome. Nat Genet 8(4):328–332PubMedCrossRef
5.
Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61(4):843–851PubMedCentralPubMedCrossRef
6.
Tarasewicz A, Dȩbska-Ślizień A, Konopa J, Zdrojewski Z, Rutkowski B (2009) Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. Transplant Proc 41(9):3677–3682PubMedCrossRef
Metadata
Title
End-stage renal disease in tuberous sclerosis complex-polycystic kidney disease contiguous gene syndrome: epidemiology, clinical manifestations and implications for transplantation
Authors
Cynthia C. Lim
Huizhuan Tan
Sobhana Thangaraju
Angeline H. M. Lai
Marjorie W. Y. Foo
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0735-9

Other articles of this Issue 9/2014

International Urology and Nephrology 9/2014 Go to the issue

Nephrology - Original Paper

Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS

Urology - Case Report

Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature

Urology - Original Paper

Novel technique for the treatment of large subcapsular renal hematoma: combined use of percutaneous drainage and urokinase injection

Urology - Original Paper

Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies

Nephrology - Original Paper

Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes

Nephrology - Review

Environmental and stressful factors affecting the occurrence of kidney stones and the kidney colic
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits